- Home
- ACET vs MTEN Comparison
ACET vs MTEN Comparison
Compare ACET & MTEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACET
- MTEN
- Stock Information
- Founded
- ACET 1947
- MTEN 2015
- Country
- ACET United States
- MTEN China
- Employees
- ACET N/A
- MTEN N/A
- Industry
- ACET Biotechnology: Pharmaceutical Preparations
- MTEN Building Products
- Sector
- ACET Health Care
- MTEN Industrials
- Exchange
- ACET Nasdaq
- MTEN Nasdaq
- Market Cap
- ACET 63.8M
- MTEN 64.3M
- IPO Year
- ACET N/A
- MTEN 2024
- Fundamental
- Price
- ACET $0.62
- MTEN $13.64
- Analyst Decision
- ACET Strong Buy
- MTEN
- Analyst Count
- ACET 7
- MTEN 0
- Target Price
- ACET $5.60
- MTEN N/A
- AVG Volume (30 Days)
- ACET 371.7K
- MTEN 121.1K
- Earning Date
- ACET 08-07-2025
- MTEN 04-30-2025
- Dividend Yield
- ACET N/A
- MTEN N/A
- EPS Growth
- ACET N/A
- MTEN N/A
- EPS
- ACET N/A
- MTEN N/A
- Revenue
- ACET N/A
- MTEN $10,120,257.00
- Revenue This Year
- ACET N/A
- MTEN N/A
- Revenue Next Year
- ACET N/A
- MTEN N/A
- P/E Ratio
- ACET N/A
- MTEN N/A
- Revenue Growth
- ACET N/A
- MTEN 23.03
- 52 Week Low
- ACET $0.45
- MTEN $3.20
- 52 Week High
- ACET $1.64
- MTEN $26.03
- Technical
- Relative Strength Index (RSI)
- ACET 36.75
- MTEN N/A
- Support Level
- ACET $0.66
- MTEN N/A
- Resistance Level
- ACET $0.73
- MTEN N/A
- Average True Range (ATR)
- ACET 0.05
- MTEN 0.00
- MACD
- ACET -0.01
- MTEN 0.00
- Stochastic Oscillator
- ACET 0.00
- MTEN 0.00
About ACET Adicet Bio Inc.
Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.
About MTEN Mingteng International Corporation Inc. Ordinary Shares
Mingteng International Corp Inc operates as an automotive mold developer and supplier in China. It provides a wide range of products including casting molds for turbocharger systems, braking systems, steering and differential systems, and other automotive system parts. Besides, it also produces molds for new energy electric vehicle motor drive systems, battery pack systems, and engineering hydraulic components, which are widely used in automobile, construction machinery, and other manufacturing industries.